|
|
|
| Webinar: Accelerating Rare Disease Treatments From Concept To Cure | The swift progression from gene discovery to mass vaccination in the development of COVID-19 vaccines set a remarkable precedent. This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey. Click here to learn more. |
|
|
|
|
By Life Science Connect Editorial Staff | How can companies improve their shipping systems, cryogenic preservation, and courier selection to keep their products viable and fully traceable from manufacturing facilities to patients? |
|
|
|
Dr. Nicole Verdun shares some of the challenges of demonstrating CMC comparability during late-stage product development (i.e., pivotal or Phase 3 clinical trial) that occur while transitioning to commercial manufacturing. |
|
|
|
|
| Effects Of Annex 1 Revisions On Manufacturing Operations | Article | By Jaime Rain, Kymanox Corporation | Revisions to EU Annex 1 set the stage for the future direction of the pharma/biotech industry. Explore some key takeaways and interesting changes for risk management and contamination control strategies. |
|
|
|
| Opportunities To Accelerate Allogeneic Cell Therapy | Article | AGC Biologics | Learn more about the potential of allogeneic cell therapies to combine the efficacy of personalized medicine with the scalability, accessibility, and uniformity of traditional off-the-shelf therapeutics. |
|
|
|
| Reflecting On ElevateBio’s First Five Years | Article | By David Hallal, ElevateBio | This is an exploration of highlights and accomplishments in each area of our businesses over the past five years, accelerating our company to where we are today. |
|
|
|
|
|
| As the patient’s immune cells are the starting materials, inherent biological variability leads to CAR-T manufacturing. Additional critical raw materials also have batch-to-batch variability, which means the entire production process is a constant balancing act of adjusting the manufacturing process to create standardized manufacturing. Join Cell & Gene Live for a discussion on practical ways to overcome the challenges associated with batch-to-batch variation. Registration is free thanks to the support of Entegris. |
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
